1. Evaluation of grading systems in stage I lung adenocarcinomas: a retrospective cohort study
   Tamás Zombori et al, 2018, Journal of Clinical Pathology CrossRef
2. High Expression of Vimentin is Associated With Progression and a Poor Outcome in Glioblastoma
   Jiaxin Zhao et al, 2018, Applied Immunohistochemistry & Molecular Morphology CrossRef
3. Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?
   Yan Wang et al, 2023, Pathology - Research and Practice CrossRef
4. Micropapillary or solid component predicts worse prognosis in pathological IA stage lung adenocarcinoma: A meta-analysis
   Yifan Wang et al, 2023, Medicine CrossRef
5. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study
   Tomoshi Tsuchiya et al, 2020, BMC Cancer CrossRef
6. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway
   Chih-Wei Chen et al, 2021, International Journal of Molecular Sciences CrossRef
7. Prevalent and up‐regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance
   Hiroyasu Nakashima et al, 2015, Pathology International CrossRef
8. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier
   Masahiro Seike et al, 2017, Oncology Reports CrossRef
9. Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma
   Ryo NAGASHIO et al, 2020, Biomedical Research CrossRef
10. Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma
    Jung-Soo Pyo et al, 2018, Pathology & Oncology Research CrossRef
11. Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy
    Cong Wang et al, 2020, Annals of Surgical Oncology CrossRef